- The Wall Street Journal•33 minutes ago
Germany’s Bayer set out ambitious sales and profit targets for this year when its expects to clinch its planned $57 billion acquisition of seeds maker Monsanto.
- TheStreet.com•1 hour ago
Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.
- Reuters•2 hours ago
German drugmaker Bayer issued muted full-year guidance for its agricultural products division on Wednesday, as it prepares to wrap up the $66 billion takeover of U.S. seed maker Monsanto later this year. Bayer's Crop Science division expects earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, to stagnate this year, the group said as it issued fourth-quarter group earnings that slightly beat market expectations.
BAYRY : Summary for BAYER AKTIENGES ADS - Yahoo Finance
Bayer Aktiengesellschaft (BAYRY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||113.90 - 115.00|
|52 Week Range||91.53 - 125.20|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.87|
|Dividend & Yield||2.87 (2.53%)|
|1y Target Est||N/A|